Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice

References

• Kuettner KE, Goldberg VM. Osteoarthritic disorders. Rosemont (IL): American Academy of Orthopedic Surgeons; 1995. p. xxi–xxv
   Google Scholar
• Oliveria SA, Felson DT, Reed JI, et al. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995;38:1134–41
   PubMed Web of Science ®Google Scholar
• Wilson MG, Michet CJ, Ilstrup DM, Melton LJ. Idiopathic symptomatic osteoarthritis of the hip and knee: a population-based incidence study. Mayo Clin Proc 1990;65: 1214–21
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005;64:669–81
   PubMed Web of Science ®Google Scholar
• Doherty M, Dougados M. Evidence-based management of osteoarthritis: practical issues relating to the data. Best Pract Res Clin Rheumatol 2001;15:517–25
   PubMed Web of Science ®Google Scholar
• Pencharz JN, Grigoriadis E, Jansz GF, Bombardier C. A critical appraisal of clinical practice guidelines for the treatment of lower-limb osteoarthritis. Arthritis Res 2002;4: 36–44
   PubMedGoogle Scholar
• Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993;39:3–9
   PubMedGoogle Scholar
• Balazs EA. Physical chemistry of hyaluronic acid. Fed Proc 1958;17:1086–93
   PubMedGoogle Scholar
• Pozo MA, Balazs EA, Belmonte C. Reduction of sensory responses to passive movements of inflamed knee joints by hylan a hyaluronan derivative. Exp Brain Res 1997;116:3–9
   Google Scholar
• Bagga H, Burkhardt D, Sambrook P, March L. Long term effects of intra-articular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol 2006;33:946–50
   PubMed Web of Science ®Google Scholar
• American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and the knee: 2000 update. Arthritis Rheum 2000;43:1905–15
   PubMed Web of Science ®Google Scholar
• Pendleton A, Arden N, Dougados M, et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000;59:936–44
   PubMed Web of Science ®Google Scholar
• Raynauld JP, Torrance GW, Band PA, et al. A prospective, randomized, pragmatic health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage 2002;10:506–17
   PubMed Web of Science ®Google Scholar
• Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Ther Res 1994;55:220–32
   Google Scholar
• Adams ME, Atkinson MH, Lussier AJ, et al. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with nonsteroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 1995;3:213–25
   PubMed Web of Science ®Google Scholar
• Tamir E, Robinson D, Koren R, et al. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clin Exp Rheumatol 2001;19:265–70
   PubMed Web of Science ®Google Scholar
• Kolarz G, Kotz R, Hochmayer I. Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 2003;32:310–9
   Google Scholar
• Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998;20:410–23
   PubMed Web of Science ®Google Scholar
• Lussier A, Cividino AA, McFarlane CA, et al. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996;23:1579–85
   PubMed Web of Science ®Google Scholar
• Dickson DJ, Hosie GJ. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Clin Res 2001;4:41–52
   Google Scholar
• Marshall KW. The current status of hylan therapy for the treatment of osteoarthritis. Today’s Ther Trends 1997;15:99–108
   Google Scholar
• Altman RD. Status of hyaluronan supplementation therapy in osteoarthritis. Curr Rheumatol Rep 2003;5:7–14
   PubMedGoogle Scholar
• Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a metaanalysis. J Am Med Assoc 2003;290:3115–21
   PubMed Web of Science ®Google Scholar
• Arrich J, Piribauer F, Mad P, et al. Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. Can Med Assoc J 2005;172:1039–43
   PubMed Web of Science ®Google Scholar
• Wang C-T, Lin J, Chang C-J, et al. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. J Bone Joint Surg Am 2004;86A:538–45
   Web of Science ®Google Scholar
• Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006;2:CD005321
   Google Scholar
• Espallargues M, Pons JM. Efficacy and safety of viscosupplementation with hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review. Int J Technol Assess Health Care 2003;19:41–56
   PubMed Web of Science ®Google Scholar
• Bragantini A, Molinaroli F. A pilot clinical evaluation of the treatment of hip osteoarthritis with hyaluronic acid. Curr Ther Res Clin Exp 1994;55:319–30
   Web of Science ®Google Scholar
• Brocq O, Tran G, Breuil U, et al. Hip osteoarthritis: short term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine 2002;69: 388–91
   Google Scholar
• Conrozier T, Bertin P, Mathieu P, et al. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study. Clin Exp Rheumatol 2003;21:605–10
   PubMed Web of Science ®Google Scholar
• Migliore A, Martin Martin LS, Alimonti A, et al. Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip. Osteoarthritis Cartilage 2003;11:305–6
   PubMed Web of Science ®Google Scholar
• Migliore A, Martin Martin LS, Valente C, et al. Intra-articular treatment with hylan G-F 20 (Synvisc) reduces NSAID consumption in patients with symptomatic osteoarthritis of the hip: preliminary clinical observations. Osteoporosis Int 2002;13:S20
   Web of Science ®Google Scholar
• Vad VB, Sakalkale D, Sculco TP, Wickiewicz TL. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint. Arch Phys Med Rehabil 2003;84:1224–6
   PubMed Web of Science ®Google Scholar
• Caglar-Yagci H, Unsal S, Yagci I, et al. Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study. Rheumatol Int 2005;25: 341–4
   Google Scholar
• Leopold SS, Battista V, Oliverio JA. Safety and efficacy of intraarticular hip injection using anatomic landmarks. Clin Orthop Relat Res 2001;391:192–7
   PubMed Web of Science ®Google Scholar
• Jackson DW, Evans NA, Thomas BM. Accuracy of needle placement into the intra-articular space of the knee. J Bone Joint Surg Am 2002;84A:1522–7
   Google Scholar
• Qvistgaard E, Kristoffersen H, Terslev L, et al. Guidance by ultrasound of intra-articular injections in the knee and hip joints. Osteoarthritis Cartilage 2001;9:512–7
   PubMed Web of Science ®Google Scholar
• Migliore A, Tormenta S, Martin Martin LS, et al. Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip. Reumatismo 2004;56;104–9
   PubMedGoogle Scholar
• Migliore A, Tormenta S, Martin Martin LS, et al. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis. Clin Rheumatol 2005;24:285–9
   PubMed Web of Science ®Google Scholar
• Migliore A, Tormenta S, Martin Martin LS, et al. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up. Clin Rheumatol 2006;25:389–93
   PubMed Web of Science ®Google Scholar
• Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991;34: 505–14
   PubMed Web of Science ®Google Scholar
• Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957:16:494–502
   PubMed Web of Science ®Google Scholar
• Lequesne MG. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997;24:779–81
   PubMed Web of Science ®Google Scholar
• Imamura K, McKinnon M, Middleton R, Black N. Reliability of a comorbidity measure: the Index of Co-Existent Disease (ICED). J Clin Epidemiol 1997;50:1011–6
   PubMed Web of Science ®Google Scholar
• Tormenta S, Migliore A, Nardis P, et al. Ultrasound pattern in a cohort of 170 patients suffering from hip osteoarthritis. Osteoarthritis Cartilage 2004;12(B), S124, p. 305
   Google Scholar
• Pavelka K. Treatment of pain in osteoarthritis. Eur J Pain 2000;4(Suppl A):23–30
   Google Scholar
• McGettigan P, Henry D. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. J Am Med Assoc 2006;296:1633–44
   PubMed Web of Science ®Google Scholar
• Sturkenboom MC, Romano F, Simon G, et al. The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum 2002;47:132–40
   PubMed Web of Science ®Google Scholar
• Page J, Henry D. Consumption of NSAIDs and the development of congestive heart failure in elderly patients: an underrecognized public health problem. Arch Intern Med 2000;160:777–84
   PubMed Web of Science ®Google Scholar
• Henry D. Non-steroidal anti-inflammatory drugs and the risk of development of congestive cardiac failure and functional renal impairment. Proceedings of the international conference on inflammopharmacology, San Francisco; 1997
   Google Scholar
• Psaty BM, Furberg CD. Cox-2 inhibitors – lessons in drug safety. New Engl J Med 2005;352:1133–5
   PubMed Web of Science ®Google Scholar
• Goldberg VM, Coutts RD. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment. Clin Orthop Relat Res 2004;419:130–7
   PubMedGoogle Scholar
• Kemper F, Gebhardt U, Meng T, Murray C. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 2005;21:1261–9
   PubMed Web of Science ®Google Scholar
• Goldberg VM, Buckwalter JA. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity. Osteoarthritis Cartilage 2005;13:216–24
   PubMed Web of Science ®Google Scholar
• Black N. Why we need observational studies to evaluate the effectiveness of health care. B Med J 1996;312(7040):1215–8
   PubMed Web of Science ®Google Scholar